India to Tajikistan: Combiflam Export Trade Route
India has recorded 5 verified shipments of Combiflam exported to Tajikistan, representing a combined trade value of $519 USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $104 USD. The leading Indian exporter is M.K.PHARMA, which accounts for 72% of total export value with 2 shipments worth $372 USD. On the buying side, M/S LLC " SHIFOISONI " is the largest importer in Tajikistan with $372 USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Tajikistan Combiflam corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $519 USD. The route is dominated by M.K.PHARMA, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's combiflam manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $104 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with combiflam's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 30.9%, placing it at rank #9 among India's top combiflam export destinations globally.
On the import side, key buyers of Indian combiflam in Tajikistan include M/S LLC " SHIFOISONI ", M S LLC SHIFOISONI. M/S LLC " SHIFOISONI " is the single largest importer with 2 shipments valued at $372 USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ3
- Primary modeSea freight
- Top portDelhi Air
Market Position
- Global rank#9
- Annual growth+30.9%
- Demand growth+27.7%
- Regulatory ease86/100
Top 10 Indian Combiflam Exporters to Tajikistan
Showing top 10 of 2 Indian suppliers exporting Combiflam to Tajikistan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M.K.PHARMA Avg $186 per shipment | 2 | $372 | 71.7% |
| 2 | M K PHARMA Avg $49 per shipment | 3 | $147 | 28.3% |
This table shows the top 10 of 2 Indian companies exporting combiflam to Tajikistan, ranked by total trade value. The listed exporters are: M.K.PHARMA, M K PHARMA. M.K.PHARMA is the dominant supplier with 2 shipments worth $372 USD, giving it a 72% market share.
Top 10 Combiflam Importers in Tajikistan
Showing top 10 of 2 known buyers in Tajikistan receiving Combiflam shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian combiflam in Tajikistan include M/S LLC " SHIFOISONI ", M S LLC SHIFOISONI. The largest importer is M/S LLC " SHIFOISONI ", accounting for $372 USD across 2 shipments — representing 72% of all combiflam imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S LLC " SHIFOISONI " | 2 | $372 | 71.7% |
| 2 | M S LLC SHIFOISONI | 3 | $147 | 28.3% |
Top 10 Combiflam Formulations Imported by Tajikistan
Showing top 10 of 2 product formulations shipped on the India to Tajikistan Combiflam route, ranked by trade value
Tajikistan imports a wide range of combiflam formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — COMBIFLAM 20 T (IBUPROFEN+ PARACETAMOL ) — accounts for $372 USD across 2 shipments. A total of 2 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | COMBIFLAM 20 T (IBUPROFEN+ PARACETAMOL ) | 2 | $372 | 71.7% |
| 2 | COMBIFLAM 20 T IBUPROFEN PARACETAMOL BATCH 1022575 EXP 9 2024 PHARMACEUTICAL GOODS | 3 | $147 | 28.3% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
Delhi Air handles the highest volume with 3 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's combiflam exports to Tajikistan are driven primarily by a handful of large-scale manufacturers. M.K.PHARMA with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Tajikistan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — M.K.PHARMA, M K PHARMA — together account for 100% of total trade value on this route. The average shipment value of $104 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as combiflam 20 t ibuprofen paracetamol batch 1022575 exp 9 2024 pharmaceutical goods, suggesting that buyers in Tajikistan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, M/S LLC " SHIFOISONI " is the largest importer with 2 shipments worth $372 USD — representing 72% of all combiflam imports from India on this route.
Route Statistics
- Trade Volume
- $519
- Avg. Shipment
- $104
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~26 days
- Annual Growth
- +30.9%
Other Combiflam Routes
Unlock the Full India to Tajikistan Combiflam Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 5 shipments on this route.
Frequently Asked Questions — India to Tajikistan Combiflam Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Combiflam to Tajikistan?
The leading Indian exporters of Combiflam to Tajikistan are M.K.PHARMA, M K PHARMA. M.K.PHARMA holds the largest market share at approximately 72% of total trade value on this route.
Q What is the total value of Combiflam exports from India to Tajikistan?
India exports Combiflam to Tajikistan worth approximately $519 USD across 5 recorded shipments. The average value per shipment is $104 USD.
Q Which ports does India use to ship Combiflam to Tajikistan?
The most active port of origin is Delhi Air with 3 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Tajikistan for Combiflam?
The average transit time for Combiflam shipments from India to Tajikistan is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Tajikistan Combiflam trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.9% with demand growth tracking at 27.7%. The route is ranked #9 among India's top Combiflam export destinations globally.
Q How many suppliers are active on the India to Tajikistan Combiflam route?
There are currently 2 active Indian suppliers exporting Combiflam to Tajikistan. The market is moderately concentrated with M.K.PHARMA accounting for 72% of total shipment value.
Q Who are the main importers of Combiflam from India in Tajikistan?
The leading importers of Indian Combiflam in Tajikistan include M/S LLC " SHIFOISONI ", M S LLC SHIFOISONI. M/S LLC " SHIFOISONI " is the largest buyer with 2 shipments worth $372 USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Tajikistan export trade corridor identified from Indian Customs (DGFT) records for Combiflam.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in Tajikistan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 5 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists